Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines

Cancer Research

Volumn 63, Issue 18, 2003, Pages 5909-5916

  Liang, Xing Jie ^a   Shen, Ding Wu ^a   Garfield, Susan ^a   Gottesman, Michael M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENITE SODIUM; CARBOPLATIN; CISPLATIN; CYSTEINE; FLUOROURACIL; FOLATE BINDING PROTEIN; LECTIN; MEMBRANE PROTEIN; METHIONINE; METHOTREXATE; SULFUR 35;

ACIDIFICATION; ARTICLE; BIOTINYLATION; CANCER CELL CULTURE; CANCER RESISTANCE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYSOSOME; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; BIOTIN; CARBON RADIOISOTOPES; CARBOPLATIN; CARRIER PROTEINS; CELL MEMBRANE; CISPLATIN; CYSTEINE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HELA CELLS; HUMANS; KB CELLS; LYSOSOMES; METHIONINE; METHOTREXATE; P-GLYCOPROTEIN; RECEPTORS, CELL SURFACE; SUCCINIMIDES; SULFUR RADIOISOTOPES; TRIIODOBENZOIC ACIDS; TRITIUM;

EID: 0141507979     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Shen, D. W., Pastan, I., and Gottesman, M. M. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins. Cancer Res., 58: 268-275, 1998.
2. Chu, G. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J. Biol. Chem., 269: 787-790, 1994.
3. Adachi, S., Obaya, A. J., Han, Z., Ramos-Desimone, N., Wyche, J. H., and Sedivy, J. M. c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle. Mol. Cell Biol., 21: 4929-4937, 2001.
4. Rong, R., He, Q., Liu, Y., Sheikh, M. S., and Huang, Y. TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-κB signaling pathway. Oncogene, 21: 1062-1070, 2002.
5. Shen, D. W., Cardarelli, C., Hwang, J., Cornwell, M., Richert, N., Ishii, S., Pastan, I., and Gottesman, M. M. Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J. Biol. Chem., 261: 7762-7770, 1986.
6. Johnson, S. W., Shen, D., Pastan, I., Gottesman, M. M., and Hamilton, T. C. Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines. Exp. Cell Res., 226: 133-139, 1996.
7. Chauhan, S. S., Liang, X-J., Su, A. W., Pai-Panandiker, A., Shen, D-W., Hanover, J. A., and Gottesman, M. M. Reduced endocytosis and altered lysosome function in cisplatin resistant cell lines. Br. J. Cancer, 88: 1327-1334, 2003.
8. Ishikawa, T., Bao, T. T., Yamane, Y., Akimaru, K., Frindrich, K., Wright, C. D., and Kuo, M. T. Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells. J. Biol. Chem., 271: 14981-14988, 1996.
9. Sharp, S. Y., Smith, V., Hobbs, S., and Kelland, L. R. Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell line. Br. J. Cancer, 78: 175-180, 1998.
10. 14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake. J. Cell. Physiol., 183: 108-116, 2000.
11. Akiyama, S., Fojo, A., Hanover, J. A., Pastan, I., and Gottesman, M. M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell Mol. Genet., 11: 117-126, 1985.
12. Shen, D. W., Akiyama, S., Schoenlein, P., Pastan, I., and Gottesman, M. M. Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes. Br. J. Cancer, 71: 676-683, 1995.
13. Suzaki, E., and Kataoka, K. Three-dimensional visualization of the Golgi apparatus: observation of Brunner's gland cells by a confocal laser scanning microscope. J. Struct. Biol., 128: 131-138, 1999.
14. Mellman, I., Fuchs, R., and Helenius, A. Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem., 55: 663-700, 1986.
15. Ishida, S., Lee, J., Thiele, D. J., and Herskowitz, I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc. Natl. Acad. Sci. USA, 99: 14298-14302, 2002.
16. Mellman, I., and Warren, G. The road taken: past and future foundations of membrane traffic. Cell, 100: 99-112, 2000.
17. Dupree, P., Parton, R. G., Raposo, G., Kurzchalia, T. V., and Simons, K. Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J. 12: 1597-1605, 1993.
18. McLauchlan, H. J., James, J., Lucocq, J. M., and Ponnambalam, S. Characterization and regulation of constitutive transport intermediates involved in trafficking from the trans-Golgi network. Cell. Biol. Int., 25: 705-713, 2001.
19. Donaldson, J. G., and Lippincott-Schwartz, J. Sorting and signaling at the Golgi complex. Cell, 101: 693-696, 2000.
20. De Renzis, S., Sonnichsen, B., and Zerial, M. Divalent Rab effectors regulate the sub-compartmental organization and sorting of early endosomes. Nat. Cell Biol., 4: 124-133, 2002.
21. Brown, F. D., Rozelle, A. L., Yin, H. L., Balla, T., and Donaldson, J. G. Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J. Cell Biol., 154: 1007-1017, 2001.
22. Niles, W. D., and Malik, A. B. Endocytosis and exocytosis events regulate vesicle traffic in endothelial cells. J. Membr. Biol., 167: 85-101, 1999.
23. Sheff, D. R., Kroschewski, R., and Mellman, I. Actin dependence of polarized receptor recycling in Madin-Darby canine kidney cell endosomes. Mol. Biol. Cell, 13: 262-275, 2002.
24. Apodaca, G. Endocytic traffic in polarized epithelial cells: role of the actin and microtubule cytoskeleton. Traffic, 2: 149-159, 2001.
25. Benjamin, S., and Glick, E. R. Export: more than one way out. Curr. Biol., 11: R361-R363, 2001.
26. Traub, L. M., and Kornfeld, S. The trans-Golgi network: a late secretory sorting station. Curr. Opin. Cell Biol., 9: 527-533, 1997.
27. Larsen, A. K., Escargueil, A. E., and Skladanowski, A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol. Ther., 85: 217-229, 2000.
28. Welsh, M. J. Acidification indication. Nature (Lond.), 352: 23-24, 1991.
29. Barasch, J., Kiss, B. Prince, A., Saiman, L., Gruenert, D., and al-Awqati, Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature (Lond.), 352: 70-73, 1991.
30. Niedner, H., Christen, R., Lin, X., Kondo, A., and Howell, S. B. Identification of genes that mediate sensitivity to cisplatin. Mol. Pharmacol., 60: 1153-1160, 2001.